Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05232292
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Samara Regional Cardiology Dispensary
- Registry
-
NCT05232292
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT05232292. Randomized; no masking; primary purpose prevention. Start 2021-10-06 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure
- Acronym
- IV-ACS&CHF
- Condition
- Acute Coronary Syndrome
- Condition
- Chronic Heart Failure
- Intervention (Biological)
- Ultrix Quadri
- Lead sponsor
- Samara Regional Cardiology Dispensary
Record details
- Record id
cardio:ct-nct05232292- Content hash
661e7b65359628b2506375749995119a6ce4a875f7ea63cc3b634ab623722c8b